Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies
Clinical and Translational Medicine · 2024-05 · 14 (5)
DOI: 10.1002/ctm2.1705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 26.05.2024. Verfasst von Li Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Neoplasms, RNA, Ribosomal, Ribosomes. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Young Top-notch Talent of Pearl River Talent Plan, Guangdong Provincial Science and Technology Project Foundation.
Abstract (Originalsprache)
Ribosomal RNA (rRNA) modifications, essential components of ribosome structure and function, significantly impact cellular proteomics and cancer biology. These chemical modifications transcend structural roles, critically shaping ribosome functionality and influencing cellular protein profiles. In this review, the mechanisms by which rRNA modifications regulate both rRNA functions and broader cellular physiological processes are critically discussed. Importantly, by altering the translational output, rRNA modifications can shift the cellular equilibrium towards oncogenesis, thus playing a key role in cancer development and progression. Moreover, a special focus is placed on the functions of mitochondrial rRNA modifications and their aberrant expression in cancer, an area with profound implications yet largely uncharted. Dysregulation in these modifications can lead to metabolic dysfunction and apoptosis resistance, hallmark traits of cancer cells. Furthermore, the current challenges and future perspectives in targeting rRNA modifications are highlighted as a therapeutic approach for cancer treatment. In conclusion, rRNA modifications represent a frontier in cancer research, offering novel insights and therapeutic possibilities. Understanding and harnessing these modifications can pave the way for breakthroughs in cancer treatment, potentially transforming the approach to combating this complex disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, China.
- Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, USA.
- Department of Dentistry, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Li Cui, Xinyuan Zhao
Förderung
- National Natural Science Foundation of China
- Young Top-notch Talent of Pearl River Talent Plan
- Guangdong Provincial Science and Technology Project Foundation
- Science Research Cultivation Program of Stomatological Hospital, Southern Medical University
Zitieren
APA
Cui, L., Zheng, J., Lin, Y., Lin, P., Lu, Y., Zheng, Y., Guo, B., & Zhao, X. (2024). Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies. Clinical and Translational Medicine, 14(5). https://doi.org/10.1002/ctm2.1705
Vancouver
Cui L, Zheng J, Lin Y, Lin P, Lu Y, Zheng Y, et al. Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies. Clinical and Translational Medicine. 2024;14(5). doi:10.1002/ctm2.1705
BibTeX
@article{Cui2024,
author = {Cui, Li and Zheng, Jiarong and Lin, Yunfan and Lin, Pei and Lu, Ye and Zheng, Yucheng and Guo, Bing and Zhao, Xinyuan},
title = {Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {5},
doi = {10.1002/ctm2.1705}
}
EUVIMED